Brind.

XOMA Royalty Corporation announced it will acquire Turnstone Biologics Corp. for cash and CVR, with Cooley LLP serving as legal counsel.

2 reports, 0 independent Updated Jun 27
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

XOMA Royalty Corporation announced it will acquire Turnstone Biologics Corp. for cash and CVR, with Cooley LLP serving as legal counsel.

Who's involved

What this event is mainly about
Cooley LLP

Keep exploring

The entities involved

  • Cooley LLP

    American international law firm

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet
  • Unknown outlet